KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,000 | -91.3% | 900 | -95.2% | 0.00% | -100.0% |
| Q4 2017 | $23,000 | +130.0% | 18,700 | +299.6% | 0.00% | – |
| Q3 2017 | $10,000 | -28.6% | 4,680 | -62.7% | 0.00% | – |
| Q2 2017 | $14,000 | +600.0% | 12,536 | +79.1% | 0.00% | – |
| Q1 2017 | $2,000 | -84.6% | 7,000 | -62.0% | 0.00% | – |
| Q4 2016 | $13,000 | -75.9% | 18,405 | +13.5% | 0.00% | -100.0% |
| Q3 2016 | $54,000 | +980.0% | 16,214 | +336.6% | 0.00% | – |
| Q2 2016 | $5,000 | -37.5% | 3,714 | -70.6% | 0.00% | – |
| Q1 2016 | $8,000 | -96.6% | 12,614 | -48.9% | 0.00% | -100.0% |
| Q4 2015 | $238,000 | – | 24,702 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |